Loading...

Glen Lewis Stimmel, PharmD

Title(s)Associate Dean for Academic Affairs
Phone+1 323 442 1463
Emailstimmel@usc.edu
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Pharm.D. from the University of California, San Francisco, and completed a one-year residency at Langley Porter Neuropsychiatric Institute in San Francisco. Dr. Stimmel is a founding member and Past President of the College of Psychiatric and Neurologic Pharmacists. He is a founding member, elected fellow, and Past President of the American College of Clinical Pharmacy, and an original member and past Chair of the Board of Pharmaceutical Specialties' Specialty Council on Psychiatric Pharmacy Practice. Dr. Stimmel has served on the Board of Directors of the American Association of Colleges of Pharmacy, and as Vice-chair of ASHP's Commission on Therapeutics. He is an elected member of the World Association for Sexual Health since 1999, and an elected member of the Sexual Medicine Society of North America since 2005.

    Dr. Stimmel has authored over 230 articles and textbook chapters in the areas of clinical psychopharmacology, expanded scope of practice for pharmacists, and pharmaco-economics of psychotropic drugs. He pioneered efforts in developing psychiatric pharmacy practice, education and residency programs, as well as investigating and securing prescriptive authority for pharmacists in California. Dr. Stimmel maintains an active clinical practice at LAC/USC Primary Care Clinics (geriatrics and rheumatology) providing psychopharmacology consultation services, and teaches clinical psychopharmacology in the Schools of Pharmacy and Medicine.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Park SH, Wackernah RC, Stimmel GL. Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants? J Pharm Pract. 2014 Feb; 27(1):71-8. PMID: 24153222.
      View in: PubMed
    2. Stimmel GL. Psychiatric pharmacy. Am J Health Syst Pharm. 2013 Feb 15; 70(4):366-7. PMID: 23370144.
      View in: PubMed
    3. Gutierrez MA, Mushtaq R, Stimmel G. Sexual dysfunction in women with epilepsy: role of antiepileptic drugs and psychotropic medications. Int Rev Neurobiol. 2008; 83:157-67. PMID: 18929080.
      View in: PubMed
    4. Stimmel GL, Gutierrez MA. Counseling patients about sexual issues. Pharmacotherapy. 2006 Nov; 26(11):1608-15. PMID: 17064206.
      View in: PubMed
    5. Stimmel GL, Gutierrez MA. Sexual dysfunction and psychotropic medications. CNS Spectr. 2006 Aug; 11(8 Suppl 9):24-30. PMID: 16871135.
      View in: PubMed
    6. Stimmel GL, Gutierrez MA. Pharmacologic treatment strategies for sexual dysfunction in patients with epilepsy and depression. CNS Spectr. 2006 Aug; 11(8 Suppl 9):31-7. PMID: 16871136.
      View in: PubMed
    7. Knox ED, Stimmel GL. Clinical review of a long-acting, injectable formulation of risperidone. Clin Ther. 2004 Dec; 26(12):1994-2002. PMID: 15823763.
      View in: PubMed
    8. Stimmel GL. Economic grand rounds: the economic burden of bipolar disorder. Psychiatr Serv. 2004 Feb; 55(2):117-8. PMID: 14762232.
      View in: PubMed
    9. McCombs JS, Shi L, Croghan TW, Stimmel GL. Access to drug therapy and substitution between alternative antidepressants following an expansion of the California Medicaid formulary. Health Policy. 2003 Sep; 65(3):301-11. PMID: 12941496.
      View in: PubMed
    10. Gutierrez MA, Stimmel GL, Aiso JY. Venlafaxine: a 2003 update. Clin Ther. 2003 Aug; 25(8):2138-54. PMID: 14512125.
      View in: PubMed
    11. McCombs JS, Shi L, Stimmel GL, Croghan TW. A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder. Clin Ther. 2002 Nov; 24(11):1939-59; discussion 1938. PMID: 12501884.
      View in: PubMed
    12. Li J, McCombs JS, Stimmel GL. Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program. J Affect Disord. 2002 Sep; 71(1-3):131-9. PMID: 12167509.
      View in: PubMed
    13. Stimmel GL, Gutierrez MA, Lee V. Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Clin Ther. 2002 Jan; 24(1):21-37. PMID: 11833834.
      View in: PubMed
    14. McCombs JS, Nichol MB, Johnstone BM, Stimmel GL, Shi J, Smith R. Antipsychotic drug use patterns and the cost of treating schizophrenia. Psychiatr Serv. 2000 Apr; 51(4):525-7. PMID: 10737831.
      View in: PubMed
    15. Gutierrez MA, Stimmel GL. Management of and counseling for psychotropic drug-induced sexual dysfunction. Pharmacotherapy. 1999 Jul; 19(7):823-31. PMID: 10417030.
      View in: PubMed
    16. McCombs JS, Nichol MB, Stimmel GL. The role of SSRI antidepressants for treating depressed patients in the California Medicaid (Medi-Cal) program. Value Health. 1999 Jul-Aug; 2(4):269-80. PMID: 16674317.
      View in: PubMed
    17. McCombs JS, Nichol MB, Stimmel GL, Shi J, Smith RR. Use patterns for antipsychotic medications in medicaid patients with schizophrenia. J Clin Psychiatry. 1999; 60 Suppl 19:5-11; discussion 12-3. PMID: 10507275.
      View in: PubMed
    18. Crismon ML, Fankhauser MP, Hinkle GH, Jann MW, Juni H, Love RC, Ray MD, Stimmel GL, Wells BG. Psychiatric pharmacy practice specialty certification process. Am J Health Syst Pharm. 1998 Aug 01; 55(15):1594-8. PMID: 9706186.
      View in: PubMed
    19. Carmichael JM, O'Connell MB, Devine B, Kelly HW, Ereshefsky L, Linn WD, Stimmel GL. Collaborative drug therapy management by pharmacists. American College of Clinical Pharmacy. Pharmacotherapy. 1997 Sep-Oct; 17(5):1050-61. PMID: 9324201.
      View in: PubMed
    20. Cung DD, Stimmel GL. Reemergence of positive symptoms after initial response to risperidone. Pharmacotherapy. 1997 Mar-Apr; 17(2):383-6. PMID: 9085334.
      View in: PubMed
    21. Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy. 1997 Jan-Feb; 17(1):10-21. PMID: 9017762.
      View in: PubMed
    22. Stimmel GL. Benzodiazepines in schizophrenia. Pharmacotherapy. 1996 Nov-Dec; 16(6 Pt 2):148S-151S; discussion 166S-168S. PMID: 8947998.
      View in: PubMed
    23. Stimmel GL. How to counsel patients about depression and its treatment. Pharmacotherapy. 1995 Nov-Dec; 15(6 Pt 2):100S-104S. PMID: 8587852.
      View in: PubMed
    24. Nichol MB, Stimmel GL, Lange SC. Factors predicting the use of multiple psychotropic medications. J Clin Psychiatry. 1995 Feb; 56(2):60-6. PMID: 7852254.
      View in: PubMed
    25. Skowron DM, Stimmel GL. Antidepressants and the risk of seizures. Pharmacotherapy. 1992; 12(1):18-22. PMID: 1549533.
      View in: PubMed
    26. McCombs JS, Nichol MB, Stimmel GL, Sclar DA, Beasley CM, Gross LS. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. J Clin Psychiatry. 1990 Jun; 51 Suppl:60-9; discussion 70-1. PMID: 2189876.
      View in: PubMed
    27. Johnson KA, Stimmel GL. Clinical druggist: a time for change. Drug Intell Clin Pharm. 1987 May; 21(5):436-7. PMID: 3582171.
      View in: PubMed
    28. Stimmel GL, Escobar JI. Antidepressants in chronic pain: a review of efficacy. Pharmacotherapy. 1986 Sep-Oct; 6(5):262-7. PMID: 3540878.
      View in: PubMed
    29. Kook KA, Stimmel GL, Wilkins JN, Spangher GG. Accuracy and safety of a priori lithium loading. J Clin Psychiatry. 1985 Feb; 46(2):49-51. PMID: 3918024.
      View in: PubMed
    30. Escobar JI, Mendoza R, Stimmel G, Kook K, Swann E, Raiss C. The DST in a large outpatient clinic: its diagnostic and predictive significance. Psychopharmacol Bull. 1984; 20(1):89-92. PMID: 6718654.
      View in: PubMed
    31. Stimmel GL, Falloon IR. Chlorpromazine plasma levels, adverse effects, and tobacco smoking: case report. J Clin Psychiatry. 1983 Nov; 44(11):420-2. PMID: 6643405.
      View in: PubMed
    32. Stimmel GL. Political and legal aspects of pharmacist prescribing. Am J Hosp Pharm. 1983 Aug; 40(8):1343-4. PMID: 6614020.
      View in: PubMed
    33. McGhan WF, Stimmel GL, Hall TG, Gilman TM. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients. Med Care. 1983 Apr; 21(4):435-44. PMID: 6843196.
      View in: PubMed
    34. Stimmel GL, McGhan WF, Wincor MZ, Deandrea DM. Comparison of pharmacist and physician prescribing for psychiatric inpatients. Am J Hosp Pharm. 1982 Sep; 39(9):1483-6. PMID: 6127948.
      View in: PubMed
    35. Stimmel GL. Antidepressants: old and new. Clin Pharm. 1982 Sep-Oct; 1(5):462-3. PMID: 7184680.
      View in: PubMed
    36. McGhan WF, Stimmel GL, Gilman TM, Segal JL. Pharmacists as drug prescribers: validation of certification exams and evaluation instruments. Eval Health Prof. 1982 Jun; 5(2):115-29. PMID: 10255917.
      View in: PubMed
    37. Stimmel GL, McGhan WF. The pharmacist as prescriber of drug therapy: the USC pilot project. Drug Intell Clin Pharm. 1981 Sep; 15(9):665-72. PMID: 7274058.
      View in: PubMed
    38. Stimmel GL. Clinical pharmacy and specialization. Drug Intell Clin Pharm. 1980 Jul-Aug; 14(7-8):540. PMID: 10247888.
      View in: PubMed
    39. Stimmel GL, McGhan WF. Pharmacists prescribe drugs in pilot project. Forum Med. 1980 Jun; 3(6):404-5. PMID: 10247166.
      View in: PubMed
    40. Allen RE, Stimmel GL. Neuroleptic dosage, duration, and tardive dyskinesia. Dis Nerv Syst. 1977 May; 38(5):385-7. PMID: 852370.
      View in: PubMed
    41. Stimmel GL. Clinical pharmacy services in mental health facilities. Hospitals. 1977 Jan 01; 51(1):71-4. PMID: 830612.
      View in: PubMed
    42. Stimmel GL. Tardive dyskinesia with low-dose, short-term neuroleptic therapy. Am J Hosp Pharm. 1976 Sep; 33(9):961-3. PMID: 984060.
      View in: PubMed
    43. Stimmel GL. American Board of Clinical Pharmacy. Drug Intell Clin Pharm. 1976 Jul; 10(7):419. PMID: 10236258.
      View in: PubMed
    44. Stimmel GL. Neuroleptics and the corpus striatum: clinical implications. Dis Nerv Syst. 1976 Apr; 37(4):219-24. PMID: 1253676.
      View in: PubMed
    45. Stimmel GL. Clinical implications of dopaminergic and cholinergic effects of neuroleptic drugs. Hosp Pharm. 1976 Feb; 11(2):50-1, 54-6. PMID: 10235740.
      View in: PubMed
    46. Stimmel GL. Clinical pharmacy practice in a community mental health center. J Am Pharm Assoc. 1975 Jul; 15(7):400-1, 18. PMID: 1133445.
      View in: PubMed
    47. Stimmel GL. Current therapeutic concepts. Schizophrenia. J Am Pharm Assoc. 1974 May; 14(5):257-64. PMID: 4857517.
      View in: PubMed